OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ENTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Entera Bio (ENTX) Earnings Date & Reports

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ENTX is expected to report earnings to rise 166.67% to -15 cents per share on November 06

Q3'25

Est.

$-0.16

Q1'25

Beat

by $0.01

Q4'24

Est.

$-0.06

Q3'24

Missed

by $0.03

Q2'24

Est.

$-0.06

The last earnings report on May 09 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 114.85K shares outstanding, the current market capitalization sits at 82.72M.

View a ticker or compare two or three

Compare

ENTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ENTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ENTX showed earnings on May 09, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a manufacturer of flu medicines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

Minrav Building - Fifth Floor

Phone

+972 25327151

Employees

Web

https://www.enterabio.com